Need to do better for #PE risk stratification, beyond reductionist models. In an @ESC_Journals#EHJ paper we show that a multimarker calculator🌡️outperforms the ESC model. Great work by @DJC6998@mmonrealriete et al #RIETE! Honored to be a part of it 👇:
https://t.co/9oY00u63KL
From the latest issue: Newman and colleagues analyze the @PERTConsortium database to demonstrate sex-based differences in the evaluation and management of patients with acute pulmonary embolism.
https://t.co/KqyVRRW9rV
#PulmonaryEmbolism@EricSecemskyMD@krosenfieldMD
MI care pathways should implement early combination therapy with statins and #ezetimibe as standard care, because delaying use of combination LLT or using high-intensity statin monotherapy is associated with avoidable harm. https://t.co/JxX6onqBcm
#JACC#cvMI#SWEDEHEART
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency - The FAIR-HF2 DZHK05 Randomized Clinical Trial
Late-breaker @ACCinTouch and simultaneously published in @JAMA_current
https://t.co/yMtVDAjOa1
We are excited to share our perspective on building a multidisciplinary Amyloidosis program from the ground up. Challenges and ways we overcame them. Thank you @ACCinTouch for the platform to share our story @TJUHospital@CU_Cardiology https://t.co/DbQA7ls0nf
We’ve shown that atrial fibrillation is associated with worse RV function in acute pulmonary embolism. Possibly explaining the increased mortality in this population. Thanks to all who stopped by yesterday at #AHA24 https://t.co/TQmsjh5HUX
Halting the progression of #ATTR amyloidosis with a single infusion. Loved to hear about the promising Phase 1 results at #AHA24—looking forward to updates from future trials!
Presented at #AHA24:
A phase 1 trial of nexiguran ziclumeran (nex-z) to treat transthyretin cardiomyopathy showed a rapid and durable reduction of 90% in serum transthyretin levels and evidence of disease stabilization. Full trial results: https://t.co/ib0n1GaRtR
1/ Published today, the Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
📷: Stepwise Approach to Perioperative Cardiac Assessment.
Exciting future ahead for PE trials! Great talk by @darki_amir Looking forward especially to the results of PE-TRACT and learning how catheter-directed interventions can impact longer term functional outcomes #PERT2024
Quinn Mallery, an internal medicine resident (!!!) looking at RV dysfunction and PE severity. Excellent talk by a rising star in #PE research. #PERT2024 Bring your #PE studies here!!!
The @LoyolaHealth team is gearing up for #PERT2024, and they’re sharing why you should be there too!
From groundbreaking research to life-saving innovations, discover why this Is a must-attend event: https://t.co/89IPjkHQei